Atea Pharmaceuticals, Inc. (AVIR) vs Kyverna Therapeutics, Inc. (KYTX)
Atea Pharmaceuticals, Inc. and Kyverna Therapeutics, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and Kyverna Therapeutics, Inc. are of similar size ($432.3M and $414.7M). Across the 9 metrics below, Atea Pharmaceuticals, Inc. leads on 6 and Kyverna Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | AVIR | KYTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (58.14%) | (87.24%) | (57.72%) |
| Return on assets | (52.99%) | (68.40%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack